Dexmedetomidine as an anesthetic adjunct is associated with reduced complications and cardiac intensive care unit length of stay after heart valve surgery.

MLA

Fan, Zhi-Wei, et al. “Dexmedetomidine as an Anesthetic Adjunct Is Associated with Reduced Complications and Cardiac Intensive Care Unit Length of Stay after Heart Valve Surgery.” BMC Anesthesiology, vol. 23, no. 1, Aug. 2023, pp. 1–11. EBSCOhost, https://doi.org/10.1186/s12871-023-02227-5.

APA

Fan, Z.-W., Tang, Y.-X., Pan, T., Zhang, H.-T., Zhang, H., Yan, D.-L., Wang, D.-J., & Li, K. (2023). Dexmedetomidine as an anesthetic adjunct is associated with reduced complications and cardiac intensive care unit length of stay after heart valve surgery. BMC Anesthesiology, 23(1), 1–11. https://doi.org/10.1186/s12871-023-02227-5

Chicago

Fan, Zhi-Wei, Yu-Xian Tang, Tuo Pan, Hai-Tao Zhang, He Zhang, Da-Liang Yan, Dong-Jin Wang, and Kai Li. 2023. “Dexmedetomidine as an Anesthetic Adjunct Is Associated with Reduced Complications and Cardiac Intensive Care Unit Length of Stay after Heart Valve Surgery.” BMC Anesthesiology 23 (1): 1–11. doi:10.1186/s12871-023-02227-5.